Asia Pac ECM and Index Rebal, Shenton Research

Ke Yan, CFA, FRM

Asia Pac ECM and Index Rebal

Asia Pac IPO & Placement Research, China Biotech

DZT Research

DZT Research is an independent Asia Pacific equity specialist. Our quantitative research covers index rebalancing flows, alongside exchange data analytics accross Asia Pacific. On the equity capital markets side, we focus on Asia Pacific ECM, especially biotech and TMT. Our lead analyst is frequently cited by international media.

Quantitative Analysis

<ul>
<li>We analyzed the latest HK SFC report for aggregate short position as of May 5th.</li>
<li>Top short increases and decreases were tabulated for one week and four week period. </li>
<li>We highlight short changes in Ganfenglithium, Picc P&amp;C, Jd, Bidu, Manulife.</li>
</ul>


We analyzed the latest HK SFC report for aggregate short position as of May 5th.
Top short increases and decreases were tabulated for one week and four week period. 
We highlight short changes in Ganfenglithium, Picc P&amp;C, Jd, Bidu, Manulife.


HK Short Interest Weekly: Ganfeng Lithium, Picc P&C, Jd, Bidu, Manulife

<ul>
<li>We analyzed the latest HK SFC report for aggregate short position as of Feb 3rd.</li>
<li>Top short increases and decreases were tabulated for one week and four week period. </li>
<li>We highlight short changes in Bidu, Manulife, Mengniu Dairy, CDF, Tencent, Baba, Anta Sports, Wuxi Bio.</li>
</ul>


We analyzed the latest HK SFC report for aggregate short position as of Feb 3rd.
Top short increases and decreases were tabulated for one week and four week period. 
We highlight short changes in Bidu, Manulife, Mengniu Dairy, CDF, Tencent, Baba, Anta Sports, Wuxi Bio.


HK Short Interest Weekly: Short Covers for Tencent, Baba, Anta, Wuxi Biologics

IPOs and Catalysts/Events, Global Equity Research Ltd

Arun George

IPOs and Catalysts/Events

Uncompromised, Independent, Conflict-Free Research

Global Equity Research Ltd

Global Equity Research was started in 2017 by a group of experienced research professionals. It was founded on a passionate belief in the importance and the need for uncompromised, independent, conflict-free research. We aim to provide differentiated and actionable primary and bottom up fundamental research.

Equity Capital Markets

Sunshine Insurance / Equity Capital Markets

<ul>
<li>
<a href="https://www.smartkarma.com/entities/sunshine-insurance-group" target="_blank" data-smartkarma-citation="entities:36464:1" rel="noopener">Sunshine Insurance (SUN HK)</a>, a Chinese life and P&amp;C insurance company, is pre-marketing a US$1.0 billion HKEx IPO, according to press reports.</li>
<li>In <a href="https://www.smartkarma.com/insights/sunshine-insurance-group-ipo-the-bull-case" target="_blank" data-smartkarma-citation="insights:85205" rel="noopener">Sunshine Insurance Group IPO: The Bull Case</a>, we highlighted the key elements of the bull case. In this note, we outline the bear case.  </li>
<li>The key elements of the bear case rest on Sunshine Life’s VNB margin decline and agent channel pressure; Sunshine P&amp;C’s regulatory pressure on premiums and the group's declining investment yield.</li>
</ul>



Sunshine Insurance (SUN HK), a Chinese life and P&amp;C insurance company, is pre-marketing a US$1.0 billion HKEx IPO, according to press reports.
In Sunshine Insurance Group IPO: The Bull Case, we highlighted the key elements of the bull case. In this note, we outline the bear case.  
The key elements of the bear case rest on Sunshine Life’s VNB margin decline and agent channel pressure; Sunshine P&amp;C’s regulatory pressure on premiums and the group's declining investment yield.


Sunshine Insurance Group IPO: The Bear Case

<ul>
<li>
<a href="https://www.smartkarma.com/entities/sunshine-insurance-group" target="_blank" data-smartkarma-citation="entities:36464:1" rel="noopener">Sunshine Insurance (SUN HK)</a>, a Chinese life and P&amp;C insurance company, is pre-marketing a US$1.0 billion HKEx IPO, according to press reports.</li>
<li>In 2020, Sunshine P&amp;C ranked seventh and Sunshine Life ranked 12th as measured by original premiums income market share, according to the CBIRC and the Insurance Association of China.</li>
<li>The key elements of the bull case rest on Sunshine Life’s robust premium growth and high persistency ratio; Sunshine P&amp;C’s underwriting profits in 9M22 and its high group solvency ratio.</li>
</ul>



Sunshine Insurance (SUN HK), a Chinese life and P&amp;C insurance company, is pre-marketing a US$1.0 billion HKEx IPO, according to press reports.
In 2020, Sunshine P&amp;C ranked seventh and Sunshine Life ranked 12th as measured by original premiums income market share, according to the CBIRC and the Insurance Association of China.
The key elements of the bull case rest on Sunshine Life’s robust premium growth and high persistency ratio; Sunshine P&amp;C’s underwriting profits in 9M22 and its high group solvency ratio.


Sunshine Insurance Group IPO: The Bull Case

<a href="https://www.smartkarma.com/entities/fwd-group-holdings" target="_blank" data-smartkarma-citation="entities:34332:1" rel="noopener">FWD Group Holdings (FWD US)</a> is a Pan-Asia insurer founded in 2013 by Richard Li. FWD is seeking to raise $2 billion through an NYSE IPO at a valuation between $13 billion and $15 billion, according to press reports. FWD has already secured $500 million in pre-deal demand from investors linked to the issuer - Li Ka Shing Foundation ($300 million), <a href="https://www.smartkarma.com/entities/pccw-ltd" target="_blank" data-smartkarma-citation="entities:873:1" rel="noopener">PCCW Ltd (8 HK)</a> ($100 million) and PCGI Holdings ($100 million). Athene Life Re, whose assets are managed by Apollo Global Management, has agreed to purchase shares worth $400 million in a concurrent private placement. As a relatively young insurer, FWD has built its market position as a Pan-Asian insurer through both organic growth and strategic acquisitions across Asia. FWD was the fastest-growing Pan-Asian life insurer in the past five years, according to NMG. In the short term, the outbreak of the Delta variant may impact the results. In the long-term, FWD’s compelling customer propositions and multi-channel distribution across different geographies within Asia will likely support further market share gains. <div class="content-highlight">FWD notes that there remains significant potential for cross-selling and up-selling to its millennial customers (59% of organic new individual policyholders in 1H21) as they advance through different life stages and gain spending power. On balance, we think that FWD has sufficient headroom to continue to gain market share while improving profitability. </div>

FWD Group Holdings (FWD US) is a Pan-Asia insurer founded in 2013 by Richard Li. FWD is seeking to raise $2 billion through an NYSE IPO at a valuation between $13 billion and $15 billion, according to press reports. FWD has already secured $500 million in pre-deal demand from investors linked to the issuer - Li Ka Shing Foundation ($300 million), PCCW Ltd (8 HK) ($100 million) and PCGI Holdings ($100 million). Athene Life Re, whose assets are managed by Apollo Global Management, has agreed to purchase shares worth $400 million in a concurrent private placement. As a relatively young insurer, FWD has built its market position as a Pan-Asian insurer through both organic growth and strategic acquisitions across Asia. FWD was the fastest-growing Pan-Asian life insurer in the past five years, according to NMG. In the short term, the outbreak of the Delta variant may impact the results. In the long-term, FWD’s compelling customer propositions and multi-channel distribution across different geographies within Asia will likely support further market share gains. FWD notes that there remains significant potential for cross-selling and up-selling to its millennial customers (59% of organic new individual policyholders in 1H21) as they advance through different life stages and gain spending power. On balance, we think that FWD has sufficient headroom to continue to gain market share while improving profitability. 

Canada

Manulife Financial Corporation provides financial protection products and investment management services to individuals, families, businesses, and groups. The Company conducts operations in Canada, the United States, and Asia, as well as reinsurance operations on a global basis.  Manulife offers products such as annuities, pension products, life insurance, health insurance, and mutual funds.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Manulife Financial (MFC CN)

HK Short Interest Weekly: Ganfeng Lithium, Picc P&C, Jd, Bidu, Manulife

We analyzed the latest HK SFC report for aggregate short position as of May 5th and highlight short interest changes in Ganfenglithium, Picc P&C,...

Ke Yan, CFA, FRM

HK Short Interest Weekly: Short Covers for Tencent, Baba, Anta, Wuxi Biologics

We analyzed the latest HK SFC report for aggregate short position as of Feb 3rd and highlight short interest changes in Bidu, Manulife, Mengniu...

Ke Yan, CFA, FRM

Sunshine Insurance Group IPO: The Bear Case

The key elements of the bear case rest on Sunshine Life’s VNB margin decline and agent channel pressure; Sunshine P&C’s regulatory pressure on...

Arun George

Sunshine Insurance Group IPO: The Bull Case

The key elements of the bull case rest on Sunshine Life’s robust premium growth and high persistency ratio; Sunshine P&C’s underwriting profits in...

Arun George

FWD Group IPO: Forward March

FWD is seeking to raise $2 bn through an NYSE IPO at a valuation between $13-15 bn, according to press reports. FWD has sufficient headroom to...

Arun George

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)